Literature DB >> 22936185

Bacterial superinfection in zoonotic cutaneous leishmaniasis.

Monir Doudi1, Mahbubeh Setorki, Manizheh Narimani.   

Abstract

BACKGROUND: Zoonotic Cutaneous Leishmaniasis (ZCL) is a polymorphic disease. It is generally accepted that bacterial superinfection may play a role in the clinical appearance of the lesions and may delay or prevent the healing process. However, the pattern of bacterial pathogens involved has rarely been investigated. MATERIAL/
METHODS: The aim of this study was to identify the bacterial species contaminating the suspected ZCL and their susceptibility to commonly used antibiotics. Microscopic examination of stained smears and cultures were used to differentiate ZCL from non-ZCL lesions in a rural area north of Isfahan, Iran from July to December 2009. Bacteria were isolated from the lesions and identified and antibiotic susceptibility was determined by standard microbiological techniques.
RESULTS: The results show that 602 (68%) of 855 patients were positive for ZCL, of which 83.4% with volcano-shape, 8.8% psoriasiform, 6.6% popular form and 1.2% with other atypical forms of ZCL. The bacteria were isolated from 66.8% of ZCL (70% of volcano-shape, 60% of psoriasiform and 25% of popular form) and 64.7% of non-ZCL lesions. The most common species were Staphylococcus aureus (41.7%) and S. epidermidis (28%) followed by Bacillus sp. Streptococcus pyogenes, Escherichia coli, Klebsiella sp., Proteus sp., Enterobacter sp. and Pseudomonas aeroginosa. Ciprofloxacin, Erythromycin, Cefazolin and Clindamycin were the most effective antibiotics.
CONCLUSIONS: Bacterial superinfection appears to be very common in ZCL, but its prevalence is not different from that of non-ZCL lesions and it has little effect on the clinical appearance of anthroponotic cutaneous Leishmaniasis (ACL). Local lesion care and management of bacterial superinfection must be considered in the treatment of ZCL.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22936185      PMCID: PMC3560647          DOI: 10.12659/msm.883345

Source DB:  PubMed          Journal:  Med Sci Monit        ISSN: 1234-1010


Background

Zoonotic Cutaneous Leishmaniasis, a vector-borne protozoal infection, is among the most important causes of chronic ulcerating skin lesions in the tropics. It is a major public health problem in many parts of the world, including Iran [1,2]. The diseases are hyperendemic in rural areas, where it may cause considerable morbidity. ZCL shows various clinical manifestations, ranging from asymptomatic infection without apparent lesions, to extensive lesions that may cause severe disfiguring [3-5]. It is generally accepted that secondary bacterial infection of the ZCL lesions may a factors that can influence the size, shape and severity of these skin lesions and also may delay or prevent the healing process [6,7]. Furthermore, it has been suggested that Leishmania parasites that are present in the skin lesions may induce a local suppressive effect, providing a better condition for the growth and survival of contaminating bacteria [8]. However, the scant evidence regarding the relationship between the secondary bacterial infection and cutaneous leishmaniasis is currently restricted to the work of El-on et al. and Edrissian et al. [9,10]. The first report is based on an investigation in experimentally infected mice and the later is the only field study on the bacterial superinfection in ZCL [9]. Therefore, because of the lack of a systematic bacteriological investigation, in the present study the secondary bacterial infection associated with the 3 clinically different forms of ZCL lesions and their susceptibility to common antibiotics were studied in naturally infected human hosts and the results were compared to non-ZCL skin lesions in patients living under similar environmental conditions in the same geographical area.

Material and Methods

Study area and population

The subjects of the study were all patients aged between 1 to 50 years (average, 9 years) with clinically suspected ZCL lesions and a disease history of 2 to 4 weeks, living in the Borkhar area, a rural district of northern Isfahan, Iran, where ZCL is highly endemic [2,11,12]. They were referred to the research center for skin diseases, Isfahan University of Medical Sciences, Isfahan, Iran by primary health care centers and private clinics, for microscopic diagnosis during a 6-month period from July to December 2009, the season during which ZCL is most common in the area [5].

Sampling and culturing methods

The lesions and the surrounding skin areas were disinfected with a single piece of cotton wool moistened with 70% alcohol. For parasitological investigation, 3 samples were collected from the edge of the lesions using a flame-sterilized lancet. Two samples were used to prepare methanol-fixed and Giemsa-stained smears for direct microscopy and observation of amastigotes. The third sample was inoculated into sterile screw top tubes containing 10 ml of Novey-Nicol-Mac Neal (NNN) medium [13] and incubated at 20–25°C. They were examined microscopically for the development of promastigotes at 2-day intervals for 2 weeks [14]. The skin lesions were regarded as non-ZCL skin lesion when no amastigotes was found in the smears after careful examination and promastigotes were not observed in the culture media after 2 weeks. No attempt was made to determine the cause of non-ZCL skin lesions. Clinically different forms of ZCL were named according to [6] with respect to their size, shape and severity of the lesions. For bacterial examination, 3 sterile cotton swabs wetted with sterile saline were moved from the center to the edge of lesions immediately after collection of samples for parasitological studies. The samples were transferred to nutrient broth (NB; Merck, Germany), blood agar (BA; Merck, Germany) and MacConkey agar (MC; Merck, Germany) separately and incubated at 37°C for 24 to 72 hours under aerobic conditions. Identification of colonies was done by Gram staining and standard biochemical tests as described by [15]. The susceptibility of bacteria to 16 common antibiotics was assessed using the Kirby-Bauer method [15] and Muller Hinton agar medium (MHA; Merck, Germany).

Statistical analysis

The Fisher’s exact test was used to evaluate and analyze the data.

Result

Amastigotes were observed in Giemsa-stained smears taken from 602 (68%) of 885 patients with clinically suspected cases of ZCL who attended Isfahan research center for skin diseases during a 6 month-period from July to December 2009. The clinical feature of the ZCL-positive skin lesions is summarized in Table 1. The median age of 9 years of the patients reflects the age distribution of ZCL in the area. Table 2 shows the prevalence of 3 clinically distinguished different forms of ZCL and the distribution of secondary bacterial infection in these lesions.
Table 1

The clinical feature of 3 different forms of ZCL present in Borkhar area, Isfahan, Iran.

Type of ZCL*Main characteristicsSize**Duration***Site****
Volcano-shapeRaised turgid margins. Central serous crust Resembles to a flattened Volcano. Painless2–32–4Face, FootLeg, Hand
PsoriasiformSuperficial with raised patches of skin covered with silvery scales Resembles psoriasis, Painless Firm-levated erythematous6–82–4FaceHandFootFace
Papular formPapule with exudative Surface, Plainless<0.53–4Upper arm

The shape was named according to Griffithis (1987);

size of ulcerated area expressed in cm;

number of weeks after first appearance of the lesions according to the patients;

the most common site of the lesions.

Table 2

Prevalence of clinically different forms of ZCL and the distribution of bacterial superinfection in Borkhar area Isfahan, Iran.

Type of ZCLNumber and% of patients
TotalInfectedNon infected
Volcano-shape502 (83.4)*355 (88.3)147 (73.5)
Psoriasiform53 (8.8)32 (8)21 (10.3)
Popular form40 (6.6)10 (2.5)30 (15)
Other atypical form7 (1.2)5 (1.2)2 (1)
Total602 (100)402 (100)200 (100)

Figures in brackets are percentages.

Among 602 patients with ZCL and 283 patients with non-ZCL skin lesions, bacteria were isolated from the skin lesions of 402 (66.8%) and 183 (64.7%), respectively. The secondary bacterial infections were observed in about 70% of volcano-shape, 60% of psoriasiform and 25% of popular forms of ZCL. Table 3 shows the 9 bacterial species isolated from the lesions. Staphylococcus aureus and S. epidermidis were the most common bacteria isolated from both ZCL and non-ZCL lesions, followed by Bacillus sp. and Streptococcus pyogenes.
Table 3

Bacterial species isolated from ZCL and non-ZCL lesions in Borkhar area Isfahan, Iran.

BacterialZCL lesions %n=453Non-ZCL Lesions %n=415
Staphylococcus aureus189 (41.7)*170 (41)
Staphylococcus epidermidis127 (28)110 (26.5)
Bacillus sp.36 (7.9)10 (2.4)
Streptococcus pyogenes30 (6.6)27 (6.5)
Escherichia coli24 (5.3)20 (4.8)
Klebsiella sp.19 (4.2)38 (9.2)
Proteus sp.11 (2.4)10 (2.4)
Enterobacter sp.10 (2.2)20 (4.8)
Pseudomonas aeroginosa7 (1.5)10 (2.4)
The bacterial species isolated from clinically different forms of ZCL is summarized in Table 4. Staphylococcus aureus and S. epidermidis were isolated from all 3 types of ZCL and they were the only species isolated from the popular form. The bacterial species isolated from volcano-shape and psoriasiforms were similar, except for Bacillus sp. and Proteus sp., which were isolated from volcano shape and S. pyogenes, which was isolated from psoriasiform (Table 4).
Table 4

Bacterial species isolated from 3 clinically different forms of ZCL.

Volcano-shapePsoriasiformPopular form
S. aureusS. aureusS. aureus
S. epidermidisS. epidermidisS. epidermidis
Bacillus sp.E. coli
E. coliKlebsiella sp.
Klebsiella sp.Enterobacter sp.
Proteus sp.P. aeroginosa
Enterobacter sp.S. pyogenes
P. aeroginosa
Only 1 bacterial species was isolated from the skin lesions of 337 (83.8%) patients with bacterial contaminated ZCL and 153 (83.6%) with non-ZCL lesions. Mixed infection with 2 or 3 bacterial species were observed in 59 (14.7%) and 6 (1.5%) of the ZCL lesions and 28 (15.3%) and 2 (1.1%) of the non-ZCL lesions, respectively. The most common combination was S. aureus and S. epidermidis. The results of in vitro testing of bacterial resistance to 16 common antibiotics are summarized in Table 5.
Table 5

Percentage resistance of bacteria isolated form ZCL lesions to common antibiotics.

AntibioticsGram Positive BacteriaGram Negative Bacteria
SaSeSpBsEcKsEsPaPs
Amoxcillin878917419960949194
Ampicillin928514499586109192
Cefazolin122010272018162511
Ceftizoxime251811193038508571
Cephalothin131120286562517538
Ciprofloxacin81012142017131315
Clindomycin404536262011151314
Cloxacillin452418113829251412
Chloramphenicol605035435070819385
Cotrimaxozole839035358078709193
Erythromycin121922106058275351
Gentamycin363020125560297159
Kanamycin302510135538315315
Neomycin232212103032203049
Penicillin96908219394929798
Tetracycline716335438960816269

Sa – Staphylococcus aureus; Se – Staphylococcus epidermidis; Sp – Streptococcus pyogenes; Bs – Bacillus sp.; Ec – Escherichia coli; Ks – Klebsiella sp.; Es – Entrobacter sp.; Pa – Pseudomonas aeroginosa; Ps – Proteus sp.

No obvious differences were observed in the pattern of resistance to antibiotics between the bacteria isolated from ZCL and non-ZCL skin lesions. The results of the present study show that secondary bacterial infections were not present in about 30%, 40% and 70% of volcano- shape, psoriasiform and popular forms of ZCL, respectively. Furthermore, the bacterial species isolated from volcano-shape and psoriasiform of ZCL were similar, and no obvious differences were observed between the clinical appearance of those with and without bacterial infection, except a more severe inflammatory reaction in the surrounding skin of those with bacterial infections. These observations suggest that the secondary bacterial infection does not have an important effect on the shape, size and severity of the skin lesions in ZCL (Figures 1–3).
Figure 1

Volcano shape.

Figure 3

Popular form.

Discussion

Many authors believe that secondary bacterial infection of skin lesions in ZCL is common, particularly in areas where the disease is endemic. However, very little empirical evidence has been provided by systematic bacteriological studies. In fact, the only field study is that reported by Edrissian et al. [10], who reported secondary bacterial infection in 26.5% of ZCL skin lesions in military personnel deployed in Khuzestan province, an endemic area for ZCL in southwest Iran. Therefore, the present report is the first study in which native patients with clinically different forms of ZCL were examined bacteriologically and compared with non-ZCL skin lesions in the patients living in the same geographical area under similar condition. In the present study, the results show that ZCL skin lesions are infected with bacterial pathogens in 66.8% of cases, and the differences in the prevalence of bacterial infection in ZCL lesions and non-ZCL lesions (64.7%) is not statistically significant (P<0.001). This finding confirms that in most cases the ZCL lesions are contaminated with potentially pathogenic bacteria, but does not support the idea that ZCL lesions are more susceptible to secondary bacterial infection as a result of a local immunosuppression induced by the parasite. Nine different species of bacteria were isolated from both the ZCL and non-ZCL lesions and S. aureus and S. epidermidis were predominant, followed by Bacillus sp., S. pyogenes, E. coli, Klebsiella sp., Enterobacter sp. and P. aeroginosa, respectively, in both cases. The high frequency of S. aureus and S. epidermidis in both ZCL and non-ZCL lesions were not unexpected, as they are common on the skin and mucous surface of healthy people. They live harmlessly on the host, but when the skin is broken for any reason, they can enter the wound and cause an infection. These bacteria produce enzymes such as fibrinolysins, hyaluronidase and lipases, which break down components of tissue and facilitate invasion [16,17]. Most of these infections are minor, causing a mild to sever inflammation, as was observed in the present study; however, they can cause serious infections and under particular circumstances these bacteria should indeed be considered as true pathogens [18]. The rather high isolation rates of Enterobacteriaceae could be due to the use of night-soil as fertilizer on farms, resulting in an environment contaminated with fecal material. Furthermore, lack of hygiene, sewage disposal, walking barefoot and playing on the farms, particularly by children, provide favorable conditions for colonization of the skin, especially of the feet and hands, by these bacteria. This also may explain the total absence of these bacteria in popular form of ZCL, which are mostly located on the face and upper arms, with the consequence of less exposure to infection. Although anaerobic cultures were not used in this study, microscopic examinations of Gram-stained smears did not suggest presence of any important anaerobic bacteria. This is not surprising in view of the erythema frequently surrounding the lesions, resulting in increased blood flow with a high oxygen concentration that inhibits the growth of anaerobic bacteria. Moreover, in the vast majority of cases the wound infections are caused by aerobic bacteria due to the lower number of anaerobic bacteria on the skin or in the environment [17]. The present study indicates that both Gram-positive and Gram-negative bacteria (except S. pyogenes) are highly resistant to penicillin, ampicillin and amoxicillin. Ciprofloxacin, cefazolin, and erythromycin are the most effective antibiotics against Gram-positive bacteria, and ciprofloxacin and clindamycin are the most effective antibiotics against Gram-negative bacteria. Bacterial resistance to antibiotics has been widely investigated all over the world, but the present study is the first in this area and there is no previous information for comparison. However, in many cases, studies are difficult to compare due to the differences in patient demographics, etiologies and infections status of ulcers.

Conclusions

In conclusion, the present findings indicate that bacterial superinfection is very common in ZCL, but not more so than non-ZCL skin lesions. The bacterial superinfection has little if any effect on clinical appearance of ZCL which is a polymorphic disease. Local lesion care and management of secondary bacterial infection are essential and anti-Leishmanial therapy in ZCL may be more effective when combined with antibiotics.
  13 in total

1.  Heterogeneity of wild Leishmania major isolates in experimental murine pathogenicity and specific immune response.

Authors:  C Kébaïer; H Louzir; M Chenik; A Ben Salah; K Dellagi
Journal:  Infect Immun       Date:  2001-08       Impact factor: 3.441

Review 2.  Cutaneous leishmaniasis.

Authors:  Mark S Bailey; Diana N J Lockwood
Journal:  Clin Dermatol       Date:  2007 Mar-Apr       Impact factor: 3.541

Review 3.  Staphylococcus aureus infections.

Authors:  F D Lowy
Journal:  N Engl J Med       Date:  1998-08-20       Impact factor: 91.245

4.  Coagulase-negative staphylococci are the most common bacteria found in cultures from the deep portions of hidradenitis suppurativa lesions, as obtained by carbon dioxide laser surgery.

Authors:  J Lapins; C Jarstrand; L Emtestam
Journal:  Br J Dermatol       Date:  1999-01       Impact factor: 9.302

5.  Bacterial infections in suspected cutaneous leishmaniasis lesions.

Authors:  G H Edrissian; M Mohammadi; A Kanani; A Afshar; R Hafezi; M Ghorbani; A R Gharagozloo
Journal:  Bull World Health Organ       Date:  1990       Impact factor: 9.408

Review 6.  The increase in risk factors for leishmaniasis worldwide.

Authors:  P Desjeux
Journal:  Trans R Soc Trop Med Hyg       Date:  2001 May-Jun       Impact factor: 2.184

7.  First detection of Leishmania major in peridomestic Phlebotomus papatasi from Isfahan province, Iran: comparison of nested PCR of nuclear ITS ribosomal DNA and semi-nested PCR of minicircle kinetoplast DNA.

Authors:  P Parvizi; I Mauricio; A M Aransay; M A Miles; P D Ready
Journal:  Acta Trop       Date:  2005-01       Impact factor: 3.112

8.  Cutaneous leishmaniasis of the Old World.

Authors:  A A Alrajhi
Journal:  Skin Therapy Lett       Date:  2003-02

9.  Leishmania major: bacterial contamination of cutaneous lesions in experimental animals.

Authors:  J el-On; R Sneier; E Elias
Journal:  Isr J Med Sci       Date:  1992-12

10.  [Zoonotic cutaneous leishmaniasis to the north of Isfahan. Human infection in 1991].

Authors:  M R Yaghoobi-Ershadi; E Javadian
Journal:  Bull Soc Pathol Exot       Date:  1995
View more
  6 in total

1.  Membranoproliferative glomerulonephritis due to visceral leishmaniasis in an HIV patient.

Authors:  Ricardo Enríquez; Ana Esther Sirvent; Sergio Padilla; Paula Toro; María Sánchez; Isabel Millán
Journal:  Am J Case Rep       Date:  2015-01-09

2.  Aerobic bacterial flora of biotic and abiotic compartments of a hyperendemic Zoonotic Cutaneous Leishmaniasis (ZCL) focus.

Authors:  Naseh Maleki-Ravasan; Mohammad Ali Oshaghi; Davoud Afshar; Mohammad Hossein Arandian; Sara Hajikhani; Amir Ahmad Akhavan; Bagher Yakhchali; Mohammad Hasan Shirazi; Yavar Rassi; Reza Jafari; Koorosh Aminian; Reza Ali Fazeli-Varzaneh; Ravi Durvasula
Journal:  Parasit Vectors       Date:  2015-01-29       Impact factor: 3.876

3.  A randomized controlled phase IIb wound healing trial of cutaneous leishmaniasis ulcers with 0.045% pharmaceutical chlorite (DAC N-055) with and without bipolar high frequency electro-cauterization versus intralesional antimony in Afghanistan.

Authors:  Hans-Christian Stahl; Faridullah Ahmadi; Ulrike Schleicher; Rainer Sauerborn; Justo Lorenzo Bermejo; Mohammed Latif Amirih; Ibrahim Sakhayee; Christian Bogdan; Kurt-Wilhelm Stahl
Journal:  BMC Infect Dis       Date:  2014-11-25       Impact factor: 3.090

4.  Coinfection of Leishmania (Viannia) braziliensis and Streptococcus pneumoniae in Multiple Cutaneous Lesions.

Authors:  Paulo R Cortes; Laura S Chiapello; David Dib; Monica V Herrero; Carmen T Nuncira; Carlos De Petris; Jose Echenique
Journal:  PLoS Negl Trop Dis       Date:  2016-03-10

5.  Rapid healing of cutaneous leishmaniasis by high-frequency electrocauterization and hydrogel wound care with or without DAC N-055: a randomized controlled phase IIa trial in Kabul.

Authors:  Ahmad Fawad Jebran; Ulrike Schleicher; Reto Steiner; Pia Wentker; Farouq Mahfuz; Hans-Christian Stahl; Faquir Mohammad Amin; Christian Bogdan; Kurt-Wilhelm Stahl
Journal:  PLoS Negl Trop Dis       Date:  2014-02-13

6.  Effect of secondary infection on epithelialisation and total healing of cutaneous leishmaniasis lesions.

Authors:  Liliane de Fátima Antonio; Marcelo Rosandiski Lyra; Maurício Naoto Saheki; Armando de Oliveira Schubach; Luciana de Freitas Campos Miranda; Maria de Fátima Madeira; Maria Cristina da Silva Lourenço; Aline Fagundes; Érica Aparecida Dos Santos Ribeiro; Leonardo Barreto; Maria Inês Fernandes Pimentel
Journal:  Mem Inst Oswaldo Cruz       Date:  2017-09       Impact factor: 2.743

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.